Additional Booster Dose of COVID-19 Vaccine Authorized for Adults Age 50 and Older & Immunocompromised Individuals
LEONARDTOWN, MD (March 31, 2022) – The U.S. Food and Drug Administration has authorized a second booster dose of either the Pfizer-BioNTech or the Moderna